The independent evidence database for peptides: research status, regulatory status, and sources.
We record what has been studied, how strong the evidence is, and how each peptide is regulated, with every fact linked to its source and retrieval date. No products, no dosing, no sellers.
- Entries
- 12
- Registered studies tracked
- 989
- PubMed records screened
- 520
- Verified regulatory rows
- 0
Explore
-
Peptide database
Entries with evidence tables, quick facts, registered trials, and sources.
-
Regulatory matrix
Status by country and WADA, each cell with an official source and date.
-
Trial data reports
Registry statistics by phase, status, start year, and sponsor, with CSV downloads.
-
Calculators
Sequence calculator, unit converter, and concentration calculator.
-
Comparisons
Side-by-side differences in evidence, research stage, and regulation.
-
Methodology
How data is collected, graded, and updated, and what it cannot show.
Latest data reports
- GLP-1 and Incretin Peptides: Registered Clinical Trials · 963 unique studies
Recently reviewed entries
-
BPC-157
In preparationTissue repair (research)
Status: Research only Evidence not yet gradedLast reviewed November 2, 2026
-
CJC-1295
In preparationGH secretagogue
Status: Research only Evidence not yet gradedLast reviewed November 2, 2026
-
Epitalon
In preparationLongevity (research)
Status: Research only Evidence not yet gradedLast reviewed November 2, 2026
-
GHK-Cu
In preparationCosmetic
Status: Cosmetic ingredient Evidence not yet gradedLast reviewed November 2, 2026
-
Ipamorelin
In preparationGH secretagogue
Status: Research only Evidence not yet gradedLast reviewed November 2, 2026
-
Retatrutide
In preparationGLP-1 / incretin
Status: Investigational Evidence not yet gradedLast reviewed November 2, 2026
How this site works
Citations come from scripts that query PubMed and ClinicalTrials.gov, and from official regulator pages recorded with a retrieval date. Entries are published for indexing only after verification. Read the editorial policy, methodology, and corrections policy.